A. Clayton  Perfall net worth and biography

A. Perfall Biography and Net Worth

Director of Enovis
A. Clayton Perfall has served as a director of the Company since September 21, 2010. Previously, he served as an Operating Executive of Tailwind Capital, a private equity fund manager focused on growing middle market companies in the Healthcare, Technology, Business Services and Industrial services sectors from 2014 through 2022. He served as the Chairman and Chief Executive Officer of Archway Marketing Services, Inc., a provider of marketing logistics and fulfillment services, from 2008 through 2013. From 2001 until 2008 Mr. Perfall served as the Chief Executive Officer and as a member of the board of directors of AHL Services, Inc. Mr. Perfall also served as the Chief Executive Officer of Union Street Acquisition Corp. from 2006 until 2008. He served as the Chief Financial Officer of Snyder Communications, Inc. from 1996 until 2000 and was previously a partner with a large international accounting firm. Mr. Perfall currently serves on the board of directors of the private company Distinct Holdings Group, LLC and previously served on the boards of directors of Comstock Holding Companies, Inc. from 2004 to 2018, Tailwind Premier Holdings, LLC, from 2015 until 2019 Archway Marketing Services, Inc. from 2008 until 2013, RT Acquisition Corp. from 2012 until 2015 and inVentiv Health, Inc. from 1999 to 2010. He served as the audit committee chairman for Comstock Holding Companies, Inc. and inVentiv Health during his time on those boards. Mr. Perfall’s significant financial expertise and experience as an audit committee chairman and public company Chief Financial Officer, combined with his substantial executive leadership background, are assets to both our Board and our Audit Committee.

What is A. Clayton Perfall's net worth?

The estimated net worth of A. Clayton Perfall is at least $1.43 million as of March 16th, 2023. Mr. Perfall owns 32,033 shares of Enovis stock worth more than $1,428,992 as of June 19th. This net worth approximation does not reflect any other investments that Mr. Perfall may own. Learn More about A. Clayton Perfall's net worth.

How do I contact A. Clayton Perfall?

The corporate mailing address for Mr. Perfall and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on A. Clayton Perfall's contact information.

Has A. Clayton Perfall been buying or selling shares of Enovis?

A. Clayton Perfall has not been actively trading shares of Enovis during the past quarter. Most recently, A Clayton Perfall sold 2,793 shares of the business's stock in a transaction on Thursday, March 16th. The shares were sold at an average price of $52.12, for a transaction totalling $145,571.16. Following the completion of the sale, the director now directly owns 32,033 shares of the company's stock, valued at $1,669,559.96. Learn More on A. Clayton Perfall's trading history.

Who are Enovis' active insiders?

Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.

Are insiders buying or selling shares of Enovis?

During the last year, insiders at the sold shares 2 times. They sold a total of 241 shares worth more than $14,673.76. The most recent insider tranaction occured on August, 7th when insider John Kleckner sold 174 shares worth more than $10,297.32. Insiders at Enovis own 2.4% of the company. Learn More about insider trades at Enovis.

Information on this page was last updated on 8/7/2023.

A. Clayton Perfall Insider Trading History at Enovis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2023Sell2,793$52.12$145,571.1632,033View SEC Filing Icon  
See Full Table

A. Clayton Perfall Buying and Selling Activity at Enovis

This chart shows A Clayton Perfall's buying and selling at Enovis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enovis Company Overview

Enovis logo
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $44.61
Low: $44.44
High: $45.13

50 Day Range

MA: $51.58
Low: $44.59
High: $59.92

2 Week Range

Now: $44.61
Low: $43.04
High: $66.14


702,494 shs

Average Volume

541,282 shs

Market Capitalization

$2.45 billion

P/E Ratio


Dividend Yield